Novocure announced that the US Food and Drug Administration (FDA) has approved the NovoTAL (Transducer Array Layout) system through a premarket approval (PMA) supplement. The NovoTAL System allows certified physicians to use the ...
Tags: Novotal System
Synta Pharmaceuticals has announced the publication of the company's first patent application covering its proprietary Hsp90-inhibitor drug conjugate (HDC) platform, which leverages the company's expertise in chaperone biology and medicinal ...
US-based biotechnology firm that develops novel anticancer therapeutics using antibody-drug conjugate (ADC) technology, ImmunoGen (IMGN) has signed a licensing agreement with Novartis, pursuant to which, Novartis has the exclusive right to ...
Tags: Immunogen, Novartis, ADC Technology
Reporters learnt from the China Food and Drug Administration (CFDA) that the government agency has approved Ginsenoside CK of Zhejiang Hisun Pharmaceutical Co., Ltd. (SHSE: 600267) to enter clinical test phase. Ginsenoside CK has ...
Astellas Pharma has announced the availability of Xtandi (enzalutamide), a new treatment for advanced prostate cancer in patients who have failed on first-line hormonal treatments and docetaxel chemotherapy, in the UK. Administered ...
Tags: Astellas, Cancer Medication
Astellas Pharma and Medivation have announced the submission of application for marketing approval of enzalutamide in Japan for the treatment of prostate cancer. The application was filed by Astellas with the Ministry of Health, Labour ...
Tags: Astellas, Marketing Application
US-based biopharmaceutical company H3 Biomedicine and China-based BGI have entered into collaboration to sequence and publish genomic data from pre-clinical cancer models. The research will focus on identifying and validating recurrent ...
Tags: Biomedicine, biopharmaceutical company, biopharmaceutical
The US Patent and Trademark Office (USPTO) has issued new patent covering OXiGENE benzosuberene-based compounds and methods of using them in tubulin polymerization inhibition. The patent protects benzosuberene-based compounds including ...
Tags: Health, OXiGENE, Oxigene Benzosuberene-Based Compounds
Lorus Therapeutics has signed a collaboration agreement with Brock University to develop new anticancer drugs based on chemical derivatives of the natural compound pancratistatin.? As part of the collaboration,Lorus will test the ...
Tags: Lorus Therapeutics, Brock University, new anticancer drugs
US Food and Drug Administration (FDA) has approved Pfizer's Bosulf (bosutinib) to treat adult patients with chronic, accelerated or blast phase Philadelphia chromosome-positive (Ph+) (CML) with resistance to prior therapy. Bosulif is a ...
Tags: bosulf, bosutinib, kinase inhibitor, Philadelphia chromosome-positive
Advanced Cancer Therapeutics (ACT) has received Phase I small business innovative research (SBIR) grant of $158,000 from the National Cancer Institute of the National Institutes of Health (NIH) to support the development of an anti cancer ...
Tags: ACT, SBIR Grant, anti cancer drug, Anticancer Drug
Results are interesting for treating skin cancer(melanoma)and nervous system tumors,known as gliomas. "Promising results"-Pablo Botella,researcher at the Institute of Chemical Technology of Valencia. Spanish researchers have ...